Compounds > fosquidone
Page last updated: 2024-08-25

fosquidone and Neoplasms

fosquidone has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornbleet, MA; Cummings, J; Eccles, DM; Leonard, RC; Nicolson, M; Smyth, JF; Stewart, ME1
Beranek, P; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J1

Other Studies

2 other study(ies) available for fosquidone and Neoplasms

ArticleYear
A phase I and pharmacology study of GR63178A, a water-soluble analogue of mitoquidone.
    Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Isoquinolines; Middle Aged; Neoplasms; Organophosphorus Compounds; Solubility; Time Factors

1992
Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week schedule.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1992, Volume: 4, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Protocols; Drug Administration Schedule; Drug Evaluation; Female; Headache; Humans; Injections, Intravenous; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Organophosphorus Compounds; Pain; Phlebitis; Remission Induction; Vomiting

1992